These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 39342890)

  • 1. Identification of sanguinarine as c-MYC transcription inhibitor through enhancing the G-quadruplex-NM23-H2 interactions.
    Zhong LT; Yuan JM; Fu WL; Zhang ZL; Li X; Ou TM; Tan JH; Huang ZS; Chen SB
    Bioorg Chem; 2024 Dec; 153():107842. PubMed ID: 39342890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Emerging Roles of Multimolecular G-Quadruplexes in Transcriptional Regulation and Chromatin Organization.
    Antariksa NF; Di Antonio M
    Acc Chem Res; 2024 Dec; 57(23):3397-3406. PubMed ID: 39555660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Discovery of 4-(4-(3-(1-(2-(piperidin-1-yl)ethyl)-1H-benzo[d]imidazole-2-yl)isoxazol-5-yl)phenyl)morpholine as a novel c-Myc inhibitor against lung cancer in vitro and in vivo.
    Gao J; Yin J; Li S; Jia P; Hong R; Chen J; Qu X; Zhang Z; Li M; Zhao H
    Eur J Med Chem; 2025 Jan; 281():117023. PubMed ID: 39531932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enabling Systemic Identification and Functionality Profiling for Cdc42 Homeostatic Modulators.
    Malasala S; Azimian F; Chen YH; Twiss JL; Boykin C; Akhtar SN; Lu Q
    bioRxiv; 2024 Jan; ():. PubMed ID: 38260445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. G-quadruplex DNA structure is a positive regulator of
    Esain-Garcia I; Kirchner A; Melidis L; Tavares RCA; Dhir S; Simeone A; Yu Z; Madden SK; Hermann R; Tannahill D; Balasubramanian S
    Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2320240121. PubMed ID: 38315865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rational fragment-based design of compounds targeting the PWWP domain of the HRP family.
    Vantieghem T; Aslam NA; Osipov EM; Akele M; Van Belle S; Beelen S; Drexler M; Paulovcakova T; Lux V; Fearon D; Douangamath A; von Delft F; Christ F; Veverka V; Verwilst P; Van Aerschot A; Debyser Z; Strelkov SV
    Eur J Med Chem; 2024 Dec; 280():116960. PubMed ID: 39461037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a novel toxicophore in anti-cancer chemotherapeutics that targets mitochondrial respiratory complex I.
    Stephenson ZA; Harvey RF; Pryde KR; Mistry S; Hardy RE; Serreli R; Chung I; Allen TE; Stoneley M; MacFarlane M; Fischer PM; Hirst J; Kellam B; Willis AE
    Elife; 2020 May; 9():. PubMed ID: 32432547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australia in 2030: what is our path to health for all?
    Backholer K; Baum F; Finlay SM; Friel S; Giles-Corti B; Jones A; Patrick R; Shill J; Townsend B; Armstrong F; Baker P; Bowen K; Browne J; Büsst C; Butt A; Canuto K; Canuto K; Capon A; Corben K; Daube M; Goldfeld S; Grenfell R; Gunn L; Harris P; Horton K; Keane L; Lacy-Nichols J; Lo SN; Lovett RW; Lowe M; Martin JE; Neal N; Peeters A; Pettman T; Thoms A; Thow AMT; Timperio A; Williams C; Wright A; Zapata-Diomedi B; Demaio S
    Med J Aust; 2021 May; 214 Suppl 8():S5-S40. PubMed ID: 33934362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sanguinarine identified as a natural dual inhibitor of AURKA and CDK2 through network pharmacology and bioinformatics approaches.
    Li X; You Q
    Sci Rep; 2024 Nov; 14(1):29608. PubMed ID: 39609491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical-Driven Amyloid Clearance for Therapeutics and Diagnostics of Alzheimer's Disease.
    Kim HY; Kim Y
    Acc Chem Res; 2024 Nov; 57(22):3266-3276. PubMed ID: 39496112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genedrive kit for detecting single nucleotide polymorphism m.1555A>G in neonates and their mothers: a systematic review and cost-effectiveness analysis.
    Shabaninejad H; Kenny RP; Robinson T; Stoniute A; O'Keefe H; Still M; Thornton C; Pearson F; Beyer F; Meader N
    Health Technol Assess; 2024 Oct; 28(75):1-75. PubMed ID: 39487741
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ceftazidime with avibactam for treating severe aerobic Gram-negative bacterial infections: technology evaluation to inform a novel subscription-style payment model.
    Harnan S; Kearns B; Scope A; Schmitt L; Jankovic D; Hamilton J; Srivastava T; Hill H; Ku CC; Ren S; Rothery C; Bojke L; Sculpher M; Woods B
    Health Technol Assess; 2024 Oct; 28(73):1-230. PubMed ID: 39487661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and optimization of novel 4-morpholinothieno[3,2-d]pyrimidine derivatives as potent BET inhibitors for cancer therapy.
    Ran K; Li Y; Zhang YM; Tang DY; Chen ZZ; Xu ZG; Zhang L; Wang BC; Huang JH
    Bioorg Chem; 2024 Dec; 153():107929. PubMed ID: 39509789
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential protein kinase inhibitors that target G-quadruplex DNA structures in the human telomeric regions.
    Banjan B; Koshy AJ; Kalath H; John L; Soman S; Raju R; Revikumar A
    Mol Divers; 2024 Oct; 28(5):3377-3391. PubMed ID: 38509417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic Field Theory of Executive Function: Identifying Early Neurocognitive Markers.
    McCraw A; Sullivan J; Lowery K; Eddings R; Heim HR; Buss AT
    Monogr Soc Res Child Dev; 2024 Dec; 89(3):7-109. PubMed ID: 39628288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using Experience Sampling Methodology to Capture Disclosure Opportunities for Autistic Adults.
    Love AMA; Edwards C; Cai RY; Gibbs V
    Autism Adulthood; 2023 Dec; 5(4):389-400. PubMed ID: 38116059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Smc5/6 complex counteracts R-loop formation at highly transcribed genes in cooperation with RNase H2.
    Roy S; Adhikary H; Isler S; D'Amours D
    Elife; 2024 Oct; 13():. PubMed ID: 39404251
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Chahine ZM; Gupta M; Lenz T; Hollin T; Abel S; Banks C; Saraf A; Prudhomme J; Bhanvadia S; Florens LA; Le Roch KG
    Elife; 2024 Dec; 12():. PubMed ID: 39636094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FL118: A potential bladder cancer therapeutic compound targeting H2A.X identified through library screening.
    Fan G; Luo X; Shi Y; Wang Y; Ji L; Gong Y; Yang E; Chen C; Cui S; Ding H; Zhang Z; Wang J; Liu Y; Wang Z
    Bioorg Chem; 2024 Dec; 153():107802. PubMed ID: 39244972
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.